The Community Guide

- gsearch

Search Results

All Collections

Morbidity and Mortality Weekly Report (MMWR)

The Morbidity and Mortality Weekly Report (MMWR) series are CDC’s primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. The MMWR series includes the following publications: MMWR Weekly, MMWR Recommendations and Reports, CDC Surveillance Summaries and MMWR Supplements. These journals are freely available to the public as Diamond Open Access. For more on MMWR, visit https://www.cdc.gov/mmwr/index.html.

Narrow Results:

Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR) 13

2024 2
2022 4
2021 1
2017 6

Puerto Rico 1
United States 7

Charts, Diagrams, Etc. 3
Map 4

1 - 13 of 13 Results

Refine Results

Refine Results:

Leading Causes of Death in Nonmetropolitan and Metropolitan Areas — United States, 1999–2014 [10 maps]

CITE Title : Leading Causes of Death in Nonmetropolitan and Metropolitan Areas — United States, 1999–2014 [10 maps] Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : January 14, 2017 Pages in Document : 5 pdf pages Series : Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR) Source : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries, 2017; v. 66, no. 1 URL : https://stacks.cdc.gov/view/cdc/43148 Journal Title : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries Centers for Disease Control and Prevention (U.S.) (2017). Leading Causes of Death in Nonmetropolitan and Metropolitan Areas — United States, 1999–2014 [10 maps]. 66(1). Centers for Disease Control and Prevention (U.S.) "Leading Causes of Death in Nonmetropolitan and Metropolitan Areas — United States, 1999–2014 [10 maps]" 66, no. 1 (2017) Centers for Disease Control and Prevention (U.S.) "Leading Causes of Death in Nonmetropolitan and Metropolitan Areas — United States, 1999–2014 [10 maps]" vol. 66, no. 1, 2017 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

January 14, 2017 | Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)

:

Percentage of Deaths from Heart Disease in Nonmetropolitan Areas that are Potentially Excess Deaths, by Public Health Region, 2014Percentage of Deaths...
Supplementary Figure for Core Report Figure. Estimated Proportion of Adults Aged ≥19 Years Who Received Selected Vaccines, by Age Group and Increased-risk Status - National Health Interview Survey, United States, 2010-2015

CITE Title : Supplementary Figure for Core Report Figure. Estimated Proportion of Adults Aged ≥19 Years Who Received Selected Vaccines, by Age Group and Increased-risk Status - National Health Interview Survey, United States, 2010-2015 Published Date : May 5, 2017 Pages in Document : 1 spreadsheet Series : Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR) Source : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries, 2017; v. 66, no. 11 URL : https://stacks.cdc.gov/view/cdc/44991 Journal Title : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries "Supplementary Figure for Core" (2017). 66(11). "Supplementary Figure for Core Report Figure. Estimated Proportion of Adults Aged ≥19 Years Who Received Selected Vaccines, by Age Group and Increased-risk Status - National Health Interview Survey, United States, 2010-2015" 66, no. 11 (2017) "Supplementary Figure for Core Report Figure. Estimated Proportion of Adults Aged ≥19 Years Who Received Selected Vaccines, by Age Group and Increased-risk Status - National Health Interview Survey, United States, 2010-2015" vol. 66, no. 11, 2017 Export RIS Citation Information.

May 5, 2017 | Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)

:

Trend Table for Core Report Figure. Estimated proportion of adults aged ≥19 years who received selected vaccines,* by age group and increased-risk s...
Supplementary Figure 2. Estimated Proportion of Adults Aged ≥19 Years Who Received a Tetanus Toxoid-containing Vaccine (Td or Tdap) and Proportion of Those Who Received Tdap, by Age Group — National Health Interview Survey, United States, 2010–2015

CITE Title : Supplementary Figure 2. Estimated Proportion of Adults Aged ≥19 Years Who Received a Tetanus Toxoid-containing Vaccine (Td or Tdap) and Proportion of Those Who Received Tdap, by Age Group — National Health Interview Survey, United States, 2010–2015 Published Date : May 5, 2017 Pages in Document : 1 figure Series : Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR) Source : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries, 2017; v. 66, no. 11 URL : https://stacks.cdc.gov/view/cdc/44994 Journal Title : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries "Supplementary Figure 2. Estimated" (2017). 66(11). "Supplementary Figure 2. Estimated Proportion of Adults Aged ≥19 Years Who Received a Tetanus Toxoid-containing Vaccine (Td or Tdap) and Proportion of Those Who Received Tdap, by Age Group — National Health Interview Survey, United States, 2010–2015" 66, no. 11 (2017) "Supplementary Figure 2. Estimated Proportion of Adults Aged ≥19 Years Who Received a Tetanus Toxoid-containing Vaccine (Td or Tdap) and Proportion of Those Who Received Tdap, by Age Group — National Health Interview Survey, United States, 2010–2015" vol. 66, no. 11, 2017 Export RIS Citation Information.

May 5, 2017 | Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary Figure 2 is a line graph of tetanus toxoid-containing and tetanus, diphtheria, and Acellular pertussis (Tdap) vaccination coverage among...
Supplementary Figure 3. Estimated Proportion of Adults Aged ≥19 Years Who Received Hepatitis a and Hepatitis B Vaccines, by Age Group and High-risk Status — National Health Interview Survey, United States, 2010–2015

CITE Title : Supplementary Figure 3. Estimated Proportion of Adults Aged ≥19 Years Who Received Hepatitis a and Hepatitis B Vaccines, by Age Group and High-risk Status — National Health Interview Survey, United States, 2010–2015 Published Date : May 5, 2017 Pages in Document : 1 figure Series : Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR) Source : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries, 2017; v. 66, no. 11 URL : https://stacks.cdc.gov/view/cdc/44993 Journal Title : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries "Supplementary Figure 3. Estimated" (2017). 66(11). "Supplementary Figure 3. Estimated Proportion of Adults Aged ≥19 Years Who Received Hepatitis a and Hepatitis B Vaccines, by Age Group and High-risk Status — National Health Interview Survey, United States, 2010–2015" 66, no. 11 (2017) "Supplementary Figure 3. Estimated Proportion of Adults Aged ≥19 Years Who Received Hepatitis a and Hepatitis B Vaccines, by Age Group and High-risk Status — National Health Interview Survey, United States, 2010–2015" vol. 66, no. 11, 2017 Export RIS Citation Information.

May 5, 2017 | Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary Figure 3 is a line graph of hepatitis A and hepatitis B vaccination coverage among adults aged ≥19 years by age group over time, where...
Supplementary Figure 1. Estimated Proportion of Adults Aged ≥19 Years Who Received Influenza and Pneumococcal Vaccines, by Age Group and Increased Risk Status — National Health Interview Survey, United States, 2010–2015

CITE Title : Supplementary Figure 1. Estimated Proportion of Adults Aged ≥19 Years Who Received Influenza and Pneumococcal Vaccines, by Age Group and Increased Risk Status — National Health Interview Survey, United States, 2010–2015 Published Date : May 5, 2017 Pages in Document : 1 figure Series : Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR) Source : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries, 2017; v. 66, no. 11 URL : https://stacks.cdc.gov/view/cdc/44995 Journal Title : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries "Supplementary Figure 1. Estimated" (2017). 66(11). "Supplementary Figure 1. Estimated Proportion of Adults Aged ≥19 Years Who Received Influenza and Pneumococcal Vaccines, by Age Group and Increased Risk Status — National Health Interview Survey, United States, 2010–2015" 66, no. 11 (2017) "Supplementary Figure 1. Estimated Proportion of Adults Aged ≥19 Years Who Received Influenza and Pneumococcal Vaccines, by Age Group and Increased Risk Status — National Health Interview Survey, United States, 2010–2015" vol. 66, no. 11, 2017 Export RIS Citation Information.

May 5, 2017 | Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)

:

Supplemental figure for Williams, Walter W. et al. "Surveillance of Vaccination Coverage among Adult Populations — United States 2015" 66, no. 11 (2...
Supplementary Figure 4. Estimated Proportion of Adults Aged ≥19 Years Who Received Herpes Zoster and Human Papillomavirus Vaccines, by Age Group — National Health Interview Survey, United States, 2010–2015

CITE Title : Supplementary Figure 4. Estimated Proportion of Adults Aged ≥19 Years Who Received Herpes Zoster and Human Papillomavirus Vaccines, by Age Group — National Health Interview Survey, United States, 2010–2015 Published Date : May 5, 2017 Pages in Document : 1 figure Series : Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR) Source : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries, 2017; v. 66, no. 11 URL : https://stacks.cdc.gov/view/cdc/44992 Journal Title : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries "Supplementary Figure 4. Estimated" (2017). 66(11). "Supplementary Figure 4. Estimated Proportion of Adults Aged ≥19 Years Who Received Herpes Zoster and Human Papillomavirus Vaccines, by Age Group — National Health Interview Survey, United States, 2010–2015" 66, no. 11 (2017) "Supplementary Figure 4. Estimated Proportion of Adults Aged ≥19 Years Who Received Herpes Zoster and Human Papillomavirus Vaccines, by Age Group — National Health Interview Survey, United States, 2010–2015" vol. 66, no. 11, 2017 Export RIS Citation Information.

May 5, 2017 | Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary Figure 4 is a line graph of herpes zoster and human papillomavirus (HPV) vaccination coverage among adults aged ≥19 years by age group...
Figure. Estimated Proportion of Adults Aged ≥19 Years Who Received Selected Vaccines, by Age Group and Risk Status — National Health Interview Survey, United States, 2010–2018

CITE Title : Figure. Estimated Proportion of Adults Aged ≥19 Years Who Received Selected Vaccines, by Age Group and Risk Status — National Health Interview Survey, United States, 2010–2018 Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.)Immunization Services Division. Published Date : 05/14/2021 Pages in Document : 1 pdf page Series : Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR) Source : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries, 2021; v. 70, no. 3 URL : https://stacks.cdc.gov/view/cdc/105534 Journal Title : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries National Center for Immunization and Respiratory Diseases (U.S.)Immunization Services Division. (2021). Figure. Estimated Proportion of Adults Aged ≥19 Years Who Received Selected Vaccines, by Age Group and Risk Status — National Health Interview Survey, United States, 2010–2018. 70(3). National Center for Immunization and Respiratory Diseases (U.S.)Immunization Services Division. "Figure. Estimated Proportion of Adults Aged ≥19 Years Who Received Selected Vaccines, by Age Group and Risk Status — National Health Interview Survey, United States, 2010–2018" 70, no. 3 (2021) National Center for Immunization and Respiratory Diseases (U.S.)Immunization Services Division. "Figure. Estimated Proportion of Adults Aged ≥19 Years Who Received Selected Vaccines, by Age Group and Risk Status — National Health Interview Survey, United States, 2010–2018" vol. 70, no. 3, 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.)Immunization Services Division.

05/14/2021 | Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)

:

Figure for: Lu P, Hung M, Srivastav A, et al. Surveillance of Vaccination Coverage Among Adult Populations — United States, 2018. MMWR Surveill Summ...
Supplementary Figure 4. Percent of coccidioidomycosis cases by earliest event month — United States, 2019

CITE Title : Supplementary Figure 4. Percent of coccidioidomycosis cases by earliest event month — United States, 2019 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 2022 July 8 Pages in Document : 1 spreadsheet Series : Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR) Source : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries, ly 8; v. 71, no. 7 URL : https://stacks.cdc.gov/view/cdc/118605 Journal Title : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries Centers for Disease Control and Prevention (U.S.) (2022). Supplementary Figure 4. Percent of coccidioidomycosis cases by earliest event month — United States, 2019. 71(7). Centers for Disease Control and Prevention (U.S.) "Supplementary Figure 4. Percent of coccidioidomycosis cases by earliest event month — United States, 2019" 71, no. 7 (2022) Centers for Disease Control and Prevention (U.S.) "Supplementary Figure 4. Percent of coccidioidomycosis cases by earliest event month — United States, 2019" vol. 71, no. 7, 2022 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

2022 July 8 | Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary figure: Surveillance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis — United States, 2019.
Supplementary Figure 1. Estimated geographic range of coccidioidomycosis

CITE Title : Supplementary Figure 1. Estimated geographic range of coccidioidomycosis Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 2022 July 8 Pages in Document : 1 pdf page Series : Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR) Source : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries, ly 8; v. 71, no. 7 URL : https://stacks.cdc.gov/view/cdc/118602 Journal Title : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries Centers for Disease Control and Prevention (U.S.) (2022). Supplementary Figure 1. Estimated geographic range of coccidioidomycosis. 71(7). Centers for Disease Control and Prevention (U.S.) "Supplementary Figure 1. Estimated geographic range of coccidioidomycosis" 71, no. 7 (2022) Centers for Disease Control and Prevention (U.S.) "Supplementary Figure 1. Estimated geographic range of coccidioidomycosis" vol. 71, no. 7, 2022 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

2022 July 8 | Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary figure: Surveillance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis — United States, 2019.
Supplementary Figure 3. Estimated geographic range of blastomycosis

CITE Title : Supplementary Figure 3. Estimated geographic range of blastomycosis Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 2022 July 8 Pages in Document : 1 pdf page Series : Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR) Source : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries, ly 8; v. 71, no. 7 URL : https://stacks.cdc.gov/view/cdc/118604 Journal Title : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries Centers for Disease Control and Prevention (U.S.) (2022). Supplementary Figure 3. Estimated geographic range of blastomycosis. 71(7). Centers for Disease Control and Prevention (U.S.) "Supplementary Figure 3. Estimated geographic range of blastomycosis" 71, no. 7 (2022) Centers for Disease Control and Prevention (U.S.) "Supplementary Figure 3. Estimated geographic range of blastomycosis" vol. 71, no. 7, 2022 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

2022 July 8 | Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary figure: Surveillance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis — United States, 2019.
Supplementary Figure 2. Estimated geographic range of histoplasmosis

CITE Title : Supplementary Figure 2. Estimated geographic range of histoplasmosis Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 2022 July 8 Pages in Document : 1 pdf page Series : Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR) Source : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries, ly 8; v. 71, no. 7 URL : https://stacks.cdc.gov/view/cdc/118603 Journal Title : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries Centers for Disease Control and Prevention (U.S.) (2022). Supplementary Figure 2. Estimated geographic range of histoplasmosis. 71(7). Centers for Disease Control and Prevention (U.S.) "Supplementary Figure 2. Estimated geographic range of histoplasmosis" 71, no. 7 (2022) Centers for Disease Control and Prevention (U.S.) "Supplementary Figure 2. Estimated geographic range of histoplasmosis" vol. 71, no. 7, 2022 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

2022 July 8 | Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary figure: Surveillance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis — United States, 2019.
Sentinel Enhanced Dengue Surveillance System — Puerto Rico, 2012–2022

CITE Title : Sentinel Enhanced Dengue Surveillance System — Puerto Rico, 2012–2022 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 05/30/2024 Series : Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR) Source : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries, 2024; v. 73, no. 3 URL : https://stacks.cdc.gov/view/cdc/153721 Journal Title : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries Centers for Disease Control and Prevention (U.S.) (2024). Sentinel Enhanced Dengue Surveillance System — Puerto Rico, 2012–2022. 73(3). Centers for Disease Control and Prevention (U.S.) "Sentinel Enhanced Dengue Surveillance System — Puerto Rico, 2012–2022" 73, no. 3 (2024) Centers for Disease Control and Prevention (U.S.) "Sentinel Enhanced Dengue Surveillance System — Puerto Rico, 2012–2022" vol. 73, no. 3, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

05/30/2024 | Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)

No Description
Supplementary Figures. Laboratory-Confirmed Influenza-Associated Hospitalizations Among Children and Adults — FluSurv-NET, United States, 2010–2023

CITE Title : Supplementary Figures. Laboratory-Confirmed Influenza-Associated Hospitalizations Among Children and Adults — FluSurv-NET, United States, 2010–2023 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 10/31/2024 Pages in Document : 18 pdf pages Series : Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR) Source : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries, 2024; v. 73, no. 6 URL : https://stacks.cdc.gov/view/cdc/162447 Journal Title : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries Centers for Disease Control and Prevention (U.S.) (2024). Supplementary Figures. Laboratory-Confirmed Influenza-Associated Hospitalizations Among Children and Adults — FluSurv-NET, United States, 2010–2023. 73(6). Centers for Disease Control and Prevention (U.S.) "Supplementary Figures. Laboratory-Confirmed Influenza-Associated Hospitalizations Among Children and Adults — FluSurv-NET, United States, 2010–2023" 73, no. 6 (2024) Centers for Disease Control and Prevention (U.S.) "Supplementary Figures. Laboratory-Confirmed Influenza-Associated Hospitalizations Among Children and Adults — FluSurv-NET, United States, 2010–2023" vol. 73, no. 6, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

10/31/2024 | Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary Figure 1. Surveillance catchment areas, Influenza Hospitalization Surveillance Network (FluSurv-NET), United States, 2003-04 through 202...